| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 08/15/2007 | EP1817040A2 Enhancer of the effect of adrenocorticoid, comprising gum arabic |
| 08/15/2007 | EP1817039A2 Treatment and prevention of epilepsy |
| 08/15/2007 | EP1817038A2 Combination comprising zd6474 and an antiandrogen |
| 08/15/2007 | EP1817037A1 Triazole compounds suitable for treating disorders that respond to modulaiont of the dopamine d3 receptor |
| 08/15/2007 | EP1817036A2 Modulators of muscarinic receptors |
| 08/15/2007 | EP1817035A1 Solid formulations of liquid biologically active agents |
| 08/15/2007 | EP1817034A1 M1 and/or m3 receptor antagonists in combination with other actives for treating respiratory disorders |
| 08/15/2007 | EP1817033A1 Treatment of inflammatory bowel disease |
| 08/15/2007 | EP1817032A2 Modulators of muscarinic receptors |
| 08/15/2007 | EP1817031A1 Novel specific caspase-10 inhibitors |
| 08/15/2007 | EP1817030A2 Inducible nitric oxide synthase dimerization inhibitors |
| 08/15/2007 | EP1817029A1 Isoxazolic derivative to relieve neuropathic pain |
| 08/15/2007 | EP1817028A2 Anti-mitotic anti-proliferative compounds |
| 08/15/2007 | EP1817027A2 Process for preparating enantiomerically pure fluvastatin sodium and a novel polymorphic form thereof |
| 08/15/2007 | EP1817026A2 Hcv inhibitors |
| 08/15/2007 | EP1817025A2 Tetrahydrocarbazoles as active agents for inhibiting vegf production by translational control |
| 08/15/2007 | EP1817024A2 Andrographolide derivatives to treat viral infections |
| 08/15/2007 | EP1817023A2 Methods and compositions for treating pain |
| 08/15/2007 | EP1817022A2 Methods for increasing the immune response in an animal |
| 08/15/2007 | EP1817021A1 Nsaid compositions exhibiting clinical superiority |
| 08/15/2007 | EP1817020A2 Histone deacetylase inhibitors |
| 08/15/2007 | EP1817019A1 Therapeutic formulations |
| 08/15/2007 | EP1817018A2 Hydrophobic polyamine amides as potent lipopolysaccharide sequestrants |
| 08/15/2007 | EP1817017A1 Antioxidant dietary supplement compositions and methods for maintaining healthy skin |
| 08/15/2007 | EP1817015A2 Pharmaceutical formulations |
| 08/15/2007 | EP1817014A1 Method of providing fast relief to a user of a nicotine chewing gum |
| 08/15/2007 | EP1817011A2 Methods and compositions for deterring abuse of orally administered pharmaceutical products |
| 08/15/2007 | EP1817006A2 Liposomal formulation for oral administration of glutathione (reduced) |
| 08/15/2007 | EP1817004A2 Combination therapy associating preferably a ceramide with a cytotoxic drug |
| 08/15/2007 | EP1816915A1 Curcuminoid compositions exhibiting synergistic inhibition of the expression and/or activity of cyclooxygenase-2 |
| 08/15/2007 | EP1816913A1 Novel compounds for treatment of cancer and disorders associated with angiogenesis function |
| 08/15/2007 | EP1816912A2 Treatment of stroke with histamine h3 inverse agonists or histamine h3 antagonists |
| 08/15/2007 | EP1816911A2 Arylpyrazoles and methods of using same for control of insect pests that bore into trees |
| 08/15/2007 | EP1718641B1 Benzimidazole derivative and its use as a ii receptor antagonist |
| 08/15/2007 | EP1697305B1 Substituted (4-aminocyclohexen-1-yl)phenyl and (4-aminocyclohexen-1-yl)pyridinyl compounds as 5-ht1f agonists |
| 08/15/2007 | EP1678191B1 Method for the direct synthesis of oligorhamnosides, composition comprising oligorhamnosides and use thereof as a medicament |
| 08/15/2007 | EP1677791A4 Nitrogen-containing fused heterocyclic compounds |
| 08/15/2007 | EP1673092B1 Heterocycle-substituted pteridine derivatives and their use in therapy |
| 08/15/2007 | EP1663244B1 Pteridine derivatives for the treatment of tnf-alpha-related diseases. |
| 08/15/2007 | EP1658292B1 Triazolopyrimidine derivatives as glycogen synthase kinase 3 inhibitors |
| 08/15/2007 | EP1656360B1 Thiazoline derivatives as selective androgen receptor modulators (sarms) |
| 08/15/2007 | EP1646620B1 Substituted piperidines as histamine h3 receptor ligands |
| 08/15/2007 | EP1638984B1 Avermectin b1 monosaccharide derivatives |
| 08/15/2007 | EP1633374B1 Composition consisting of alkane dicarboxylic acids and a pharmaceutically active ingredient |
| 08/15/2007 | EP1613327B1 Pharmaceutical combination containing tamsulosin and a non-steroidal anti-inflammatory drug |
| 08/15/2007 | EP1597235B1 Non-nucleoside reverse transcriptase inhibitors |
| 08/15/2007 | EP1569896B1 Tetrahydro-naphthalene derivatives |
| 08/15/2007 | EP1554280B1 Antidiabetic beta-amino heterocyclic dipeptidyl peptidase inhibitors |
| 08/15/2007 | EP1549642B1 6-methylpyridine derivative, method for preparing thereof and antiviral pharmaceutical composition comprising the same |
| 08/15/2007 | EP1543001B1 Pyrazolopyridine derivatives as tgf beta signal transduction inhibitors for the treatment of cancer |
| 08/15/2007 | EP1542705B1 Anticoagulant composition |
| 08/15/2007 | EP1539759B1 Novel imidazopyridines and their use |
| 08/15/2007 | EP1539719B1 Benzotriazol-1-ylamino-acetonitrile compounds and the use thereof in pest control |
| 08/15/2007 | EP1534715B1 Furopyridine and furopyrimidine derivatives for the treatment of hyper-proliferative disorders |
| 08/15/2007 | EP1496904B1 Use of pharmaceuticals containing n, n'-disubstituted piperazine compounds |
| 08/15/2007 | EP1496059B1 Fused bicyclic pyrimidine derivatives |
| 08/15/2007 | EP1490371B1 Thiophene-based tricyclic compounds and pharmaceutical compositions comprising same |
| 08/15/2007 | EP1487440B1 A use of a synergistic formulation of antifungal agents for the treatment of fungal infections |
| 08/15/2007 | EP1480640B1 Peroxisome proliferator activated receptor modulators |
| 08/15/2007 | EP1469845B1 Derivatives of haloacetamidobenzoic acid and use thereof for the treatment of parasitic diseases |
| 08/15/2007 | EP1467974B1 Benzimidazole derivatives and their use as gnrh antagonists |
| 08/15/2007 | EP1451196B1 The use of substituted tetracyclic imidazole derivatives as anti-histaminics |
| 08/15/2007 | EP1448531B1 3-cyanoquinolines as inhibitors of egf-r and her2 kinases |
| 08/15/2007 | EP1442023B1 Crystalline sodium salt of telmisartan and the use of the same as an angiotensin antagonist |
| 08/15/2007 | EP1440069B1 4-(6-membered)-heteroaryl acyl pyrrolidine derivatives as hcv inhibitors |
| 08/15/2007 | EP1437349B1 Substituted isoxazoles and the use thereof as antibiotics |
| 08/15/2007 | EP1435947B1 2-phenyl benzimidazoles and imidazo-¬4,5|-pyridines as cds1/chk2-inhibitors and adjuvants to chemotherapy or radiation therapy in the treatment of cancer |
| 08/15/2007 | EP1385825B1 Substituted 2-pyridine-cyclohexane-1,4-diamine derivatives |
| 08/15/2007 | EP1377590B1 Thiazolopyrimidine derivatives and use thereof as antagonists of the cx3cr1 receptor |
| 08/15/2007 | EP1368028B1 Benzimidazole compounds for modulating ige and inhibiting cellular proliferation |
| 08/15/2007 | EP1363668B1 Combinations of bile acid sequestrant(s) and sterol absorption inhibitor(s) and treatments for vascular indications |
| 08/15/2007 | EP1357899B1 Oral itraconazole formulations and methods of making the same |
| 08/15/2007 | EP1355887B1 Pyrimidine acyclonucleoside derivatives, preparation method and use thereof |
| 08/15/2007 | EP1355588B1 Device for delivery of therepeutic agents |
| 08/15/2007 | EP1354879B1 Dihydronaphthalene derivative compounds and drugs containing these compounds as the active ingredient |
| 08/15/2007 | EP1353669B1 Method for treating glaucoma |
| 08/15/2007 | EP1343488B1 Treatment of statin side effects |
| 08/15/2007 | EP1339458B1 Combination comprising an agent decreasing vegf activity and an agent decreasing egf activity |
| 08/15/2007 | EP1328535B1 Macrolides |
| 08/15/2007 | EP1328288B1 Protein mixtures for wound healing |
| 08/15/2007 | EP1328281B1 Compositions and methods for treating females sexual response |
| 08/15/2007 | EP1322596B1 Zwitterionic tachykinin receptor antagonists |
| 08/15/2007 | EP1294439B1 Shelf storage stable iontophoresis reservoir-electrode and iontophoretic system |
| 08/15/2007 | EP1292568B1 Benzamide ligands for the thyroid receptor |
| 08/15/2007 | EP1272614B1 Differentiation of bone marrow cells into neuronal cells and uses therefor |
| 08/15/2007 | EP1259242B1 Use of pdgf receptor tyrosine kinase inhibitors for the treatment of diabetic nephropathy |
| 08/15/2007 | EP1252171B1 Method for preparing functionalised beta-(1,3)-glucan derivatives |
| 08/15/2007 | EP1250137B1 Jak/stat pathway inhibitors and the use thereof for the treatment of primary generalized osteoarthritis |
| 08/15/2007 | EP1238070B1 Therapeutically useful synthetic oligonucleotides |
| 08/15/2007 | EP1222922B1 Method for stabilizing benzimidazole compounds |
| 08/15/2007 | EP1196174B1 Dietary calcium as a supplement to vitamin d compound treatment of multiple sclerosis |
| 08/15/2007 | EP1192149B1 1,4-dithiin and 1,4-dithiepin- 1,1,4,4, tetroxide derivatives useful as antagonists of the human galanin receptor |
| 08/15/2007 | EP1189606B1 Novel iron chelators and pharmaceutical compositions comprising iron chelators for the treatment of neurodegenerative disorders |
| 08/15/2007 | EP1187628B1 Metabolic intervention with glp-1 or its biologically active analogues to improve the function of the ischemic and reperfused brain |
| 08/15/2007 | EP1108023B1 Page-4, an x-linked gage-like gene expressed in normal and neoplastic prostate, testis and uterus, and uses therefor |
| 08/15/2007 | EP1086952B1 Anti aptotosis AGENTS |
| 08/15/2007 | EP1073432B1 Use of d-serine or d-alanine for treating schizophrenia |
| 08/15/2007 | EP1067933B1 Semi-synthetic ecteinascidins |
| 08/15/2007 | EP1039896A4 Method and composition for delivering zinc to the nasal membrane |
| 08/15/2007 | EP0869975B1 Assay for and uses of peptide hormone receptor ligands |